D Neofytos
Overview
Explore the profile of D Neofytos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
641
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pradier A, Mamez A, Stephan C, Giannotti F, Masouridi-Levrat S, Wang S, et al.
Ann Oncol
. 2022 Sep;
33(12):1333-1335.
PMID: 36116692
No abstract available.
2.
Schreiber P, Laager M, Boggian K, Neofytos D, van Delden C, Egli A, et al.
J Hosp Infect
. 2022 Jul;
128:47-53.
PMID: 35840001
Background: Among hospital-acquired infections, surgical site infections (SSIs) are frequent. SSI in the early post-transplant course poses a relevant threat to transplant recipients. Aim: To determine incidence, risk factors for...
3.
Coste A, Kritikos A, Li J, Khanna N, Goldenberger D, Garzoni C, et al.
Infection
. 2020 Jul;
48(5):761-766.
PMID: 32661647
Echinocandins represent the first-line therapy of candidemia. Echinocandin resistance among Candida spp. is mainly due to acquired FKS mutations. In this study, we report the emergence of FKS-mutant Candida albicans/glabrata...
4.
Kritikos A, Neofytos D, Khanna N, Schreiber P, Boggian K, Bille J, et al.
Clin Microbiol Infect
. 2018 Jun;
24(11):1214.e1-1214.e4.
PMID: 29909005
Objectives: Echinocandins represent the first-line treatment of candidaemia. Acquired echinocandin resistance is mainly observed among Candida albicans and Candida glabrata and is associated with FKS hotspot mutations. The commercial Sensititre...
5.
Neofytos D, Chatzis O, Nasioudis D, Boely Janke E, Doco Lecompte T, Garzoni C, et al.
Transpl Infect Dis
. 2018 Apr;
20(4):e12898.
PMID: 29668068
Background: There is lack of recent multicenter epidemiological data on invasive aspergillosis (IA) among solid organ transplant recipient (SOTr) in the mold-acting antifungal era. We describe the epidemiology and outcomes...
6.
Gencay M, Seffner A, Pabinger S, Gautier J, Gohl P, Weizenegger M, et al.
J Viral Hepat
. 2018 Apr;
25(10):1132-1138.
PMID: 29660206
An important requirement for a state-of-the-art hepatitis B surface antigen (HBsAg) screening assay is reliable detection of mutated HBsAg. Currently, there is a striking shortage of data regarding the detection...
7.
Durand C, Marr K, Ostrander D, Subramanian A, Valsamakis A, Cox A, et al.
Transpl Infect Dis
. 2015 Nov;
18(1):146-9.
PMID: 26565742
Background: Ventricular assist devices (VADs) have been associated with immune activation and sensitization. We observed several cases of false-positive (FP) hepatitis C virus (HCV) antibody (Ab) tests in patients being...
8.
Neofytos D, Ostrander D, Shoham S, Laverdiere M, Hiemenz J, Nguyen H, et al.
Transpl Infect Dis
. 2015 Sep;
17(6):831-7.
PMID: 26346408
Background: Voriconazole (VOR) levels are highly variable, with potential implications to both efficacy and safety. We hypothesized that VOR therapeutic drug monitoring (TDM) will decrease the incidence of treatment failures...
9.
Treatment and outcomes of Candida osteomyelitis: review of 53 cases from the PATH Alliance® registry
Neofytos D, Huprikar S, Reboli A, Schuster M, Azie N, Franks B, et al.
Eur J Clin Microbiol Infect Dis
. 2013 Aug;
33(1):135-41.
PMID: 23907587
Candida osteomyelitis is associated with significant morbidity; however, data on the management of Candida osteomyelitis are limited. The Prospective Antifungal Therapy (PATH) Alliance® registry is a comprehensive, multicenter, prospective, observational...
10.
Huprikar S, Bosserman E, Patel G, Moore A, Pinney S, Anyanwu A, et al.
Am J Transplant
. 2013 Jul;
13(9):2418-25.
PMID: 23837488
Although Trypanosoma cruzi, the parasite that causes Chagas disease, can be transmitted via organ transplantation, liver and kidney transplantation from infected donors may be feasible. We describe the outcomes of...